内吞作用
网格蛋白
生物物理学
材料科学
内吞循环
共域化
细胞内
纳米技术
超分子化学
癌细胞
溶酶体
自组装
纳米结构
细胞
化学
细胞生物学
结晶学
生物
生物化学
晶体结构
癌症
遗传学
酶
作者
Xue‐Quan Zhou,Maria Mytiliniou,Jonathan Hilgendorf,Ye Zeng,Panagiota Papadopoulou,Yang Shao,Maximilian Paradiz Domínguez,Liyan Zhang,Marcel B. S. Hesselberth,Erik Bos,Maxime A. Siegler,Francesco Buda,Albert M. Brouwer,Alexander Kros,Roman I. Koning,Doris Heinrich,Sylvestre Bonnet
标识
DOI:10.1002/adma.202008613
摘要
Many drug delivery systems end up in the lysosome because they are built from covalent or kinetically inert supramolecular bonds. To reach other organelles, nanoparticles hence need to either be made from a kinetically labile interaction that allows re-assembly of the nanoparticles inside the cell following endocytic uptake, or, be taken up by a mechanism that short-circuits the classical endocytosis pathway. In this work, the intracellular fate of nanorods that self-assemble via the Pt…Pt interaction of cyclometalated platinum(II) compounds, is studied. These deep-red emissive nanostructures (638 nm excitation, ≈700 nm emission) are stabilized by proteins in cell medium. Once in contact with cancer cells, they cross the cell membrane via dynamin- and clathrin-dependent endocytosis. However, time-dependent confocal colocalization and cellular electron microscopy demonstrate that they directly move to mitochondria without passing by the lysosomes. Altogether, this study suggests that Pt…Pt interaction is strong enough to generate emissive, aggregated nanoparticles inside cells, but labile enough to allow these nanostructures to reach the mitochondria without being trapped in the lysosomes. These findings open new venues to the development of bioimaging nanoplatforms based on the Pt…Pt interaction.
科研通智能强力驱动
Strongly Powered by AbleSci AI